ZimVie to sell to investment firm for about $730M
The announcement follows reports that the dental equipment company was considering a sale after receiving takeover offers.
ZimVie to sell to investment firm for about $730M Read More »
Uncategorized
Hospitals are buying more doctor’s offices. That’s tied to higher costs, study finds
A new National Bureau of Economic Research analysis links hospital-physician consolidation to lower competition and higher costs down the line. The American Hospital Association slammed the study as flawed.
Hospitals are buying more doctor’s offices. That’s tied to higher costs, study finds Read More »
Sanofi Makes $1.6B Vaccine Bet With Vicebio Acquisition
The acquisition, which will give Sanofi a combination vaccine for respiratory syncytial virus and human metapneumovirus, follows the pharma’s potential $1.4 billion COVID vaccine licensing deal with Novavax last year, plus a number of other big-ticket commitments outside of the vaccine space.
Sanofi Makes $1.6B Vaccine Bet With Vicebio Acquisition Read More »
Avalyn Pharma Adds $100M Series D for Inhaled Pulmonary Fibrosis Drugs
The company is pushing inhaled versions of common oral drugs with the hope of avoiding severe side effects.
Avalyn Pharma Adds $100M Series D for Inhaled Pulmonary Fibrosis Drugs Read More »
Sarepta Concedes to FDA Request, Suspends US Shipments of Elevidys
After initially refusing to suspend Elevidys distribution after two deaths, Sarepta has now given in to the FDA’s request, noting the need to maintain a good working relationship with the regulator.
Sarepta Concedes to FDA Request, Suspends US Shipments of Elevidys Read More »
Why Countries are Racing to Build mRNA Factories While America Hesitates on Next-Gen Vaccines
In this episode presented by Eclipsebio, BioSpace’s head of insights Lori Ellis continues the discussion on mRNA and srRNA with Andy Geall of Replicate Bioscience and Alliance for mRNA Medicines, and Pad Chivukula of Arcturus Therapeutics.
Concentra Buys Beleaguered iTeos at Slight Discount
In May, biotech iTeos Therapeutics decided to close down after being abandoned by GSK over the disappointing mid-stage performance of its anti-TIGIT antibody belrestotug.
Concentra Buys Beleaguered iTeos at Slight Discount Read More »
With Potential Tariffs Weeks Away, AstraZeneca Makes $50B U.S. Manufacturing Push
The money will focus on a manufacturing plant in Virginia that will make the company’s weight management and metabolic drugs like the hypertension drug baxdrostat and oral GLP-1 therapies.
With Potential Tariffs Weeks Away, AstraZeneca Makes $50B U.S. Manufacturing Push Read More »
Hallan la flor más antigua de Argentina
Unas científicas han descubierto la flor fósil más antigua registrada hasta el momento en Argentina. Se trata de una nueva especie, a la cual se le ha dado el nombre de Stellula meridionalis (pequeña estrella del sur). La flor fue identificada a partir de un conjunto de f …
¿Es útil ChatGPT para aprender idiomas?
Ante el creciente número de personas que recurren a ChatGPT cuando estudian un idioma extranjero, una investigación pionera revela el potencial y las carencias de los procesos de aprendizaje de segundas lenguas por esta vía. Según esta investigación, reali …